Return to Listing

1 result(s) for

PI Name Protocol # Title
Jeremy Cetnar STUDY00020077 [NCI CIRB] S1800A - A Phase II Randomized Study of Ramucirumab Plus MK3475 (Pembrolizumab) Versus Standard of Care For Patients Previously Treated With Immunotherapy For Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP Non-Matched Sub-Study)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080